Scientific Program

Keynote

Misinformation in Science
Adam Berinsky, MIT Political Science
Monday, June 24, 2024

Preceded by the Wolfgang & Patricia Joklik Distinguished Service Award

SYMPOSIUM I - TUESDAY
Artificial Intelligence (AI), Machine Learning and Computation in Virology

"Computational Approaches to Viral Assembly"
Michael F. Hagan, Brandeis University

"Accelerating antiviral discovery with machine learning"
Alpha Lee, University of Cambridge

"Deep Machine Learning and Biophysics to Forecast Viral Escape"
Debora Marks, Havard Medical School

"Machine Learning Platforms to Study Host-Pathogen Balance in Virology"
William Balch, The Scripps Research Institute

ASV 2024 Ann Palmenberg Junior Investigator Awardees

SYMPOSIUM II - WEDNESDAY
Virus-Host Interactions: Structural Virology, Innate Antiviral Immunity, and More

"Global Perspectives on Zoonotic and Interspecies Transmission of Coronaviruses and Disease “X”"
Linda Saif, The Ohio State University

"Interactions of Intestinal Microbiota with Viral Pathogens and Mucosal Innate Immunity"
Megan Baldridge, Washington University, St. Louis

"Viral Class II Membrane Fusion Machinery Derives from an Ancestral Precursor"
Felix Rey, Institut Pasteur

"Correlative Multi-Scale Cryo-Imaging to Study Viral Assembly And Egress"
Peijun Zhang, University of Oxford

SYMPOSIUM III - THURSDAY
Translating Basic Science to Development of Antivirals and Vaccines

"Field Responses to Ebola and Monkeypox"
Inger Damon, Centers for Disease Control and Prevention

"Virus Evolution and the Quest for Live-Attenuated Vaccines"
Raul Andino, UCSF

"Antibodies Against Emerging Viruses"
Erica Ollmann Saphire, La Jolla Institute for Immunology

"Dissecting Picornavirus Virulence and Persistence: Key Insights for Enhanced Vaccines and Therapeutics"
Diego Diel, Cornell University

"From Nanotechnology to mRNA Vaccines: How Overcoming Skepticism Led to New Medical Treatments and Ways to Tackle a Global Health Challenge"
Robert Langer, MIT

SYMPOSIUM IV - FRIDAY
The Transformation of Virology Research and
Global Health

"The Global Rotavirus Vaccination Program: Successes and Challenges"
Jacqueline Tate, Centers for Disease Control and Prevention

"A Perspective on Transformations in Basic Research and Vaccine Development"
Gail Williams Wertz, College of William & Mary

"Exploring Viral Mediators of Cancer in Africa: A New Africa-Based Research Institute Targeting The Intersect Of Cancer and Infectious Diseases"
Robert F. Breiman, Emory University, University of the Witwatersrand

"The Climate Amplified Diseases and Epidemics (CLIMADE) Consortium"
Tulio de Oliveira, University of KwaZulu-Natal and Stellenbosch University, South Africa

"SARS-Cov-2 and Influenza: Lessons from Pandemic Respiratory Viruses"
Kanta Subbarao, University of Melbourne

State-of-the-Art Lectures

“Multiomic characterization of past viral infections”
Daniel Blanco-Melo, Fred Hutchinson Cancer Research Center

“Genetic diversity and evolutionary convergence of cryptic SARS‑CoV‑2 lineages detected via wastewater sequencing”
John Dennehy, Queens College and The Graduate Center of The City University of New York

"Transmission and pathogenesis of emerging arboviruses"
Nisha Duggal, Virginia Polytechnic Institute and State University

“Molecular and immunological drivers of viral disease severity”
Juliet Morrison, University of California, Riverside

“Revealing the tropism of tick-borne flavivirus in the brain using whole tissue ex vivo imaging”
Anna Överby Wernstedt, Umeå University

"The limits of the virosphere: a journey into the world of giant viruses"
Jônatas Santos Abrahão, Federal University of Minas Gerais (Universidade Federal de Minas Gerais)

Satellite Symposia

Invertebrate Virology: Unique and Conserved Aspects of Virus-Host Interactions

Organizer: Michelle Flenniken, Montana State University
Councilor for Invertebrate Virology

The 2024 Invertebrate Virology Satellite Symposium will showcase cutting-edge research on antiviral defense mechanisms and the intricate interactions between viruses and their invertebrate hosts. Talks will highlight results from model organisms, including Drosophila melanogaster and Caenorhabditis elegans, insect vectors of human and animal viruses, such as mosquitos and ticks, and parasitoid wasps and their symbiotic viruses. The symposium is poised to be an exciting forum for the exchange of ideas from various perspectives at the forefront of invertebrate virology research.

Speakers

When viruses turn good: Parasitoid wasps as models for understanding mutualistic virus evolution
Kelsey Coffman
, University of Tennessee

Mosquito antiviral immunity: Navigating broadly conserved innate responses
Claudia Rückert
, University of Nevada, Reno

What worms can teach us about viral infections
David Wang, Washington University in St. Louis

cGAS/STING-mediated immunity: Lessons from insects
JeanLuc Imler, Institut de Biologie Moleculaire et Cellulaire

The impact of host biological factors on arbovirus infection and transmission by mosquitoes
James Weger-Lucarelli, Virginia Tech

Evolution & mechanism of cGAS-like receptors in antiviral immunity
Yao Li, Harvard Medical School

 

 

A Veterinary Virapalooza: Improving the Control of Viral Diseases of Animals

Organizer: Andrew Broadbent, University of Maryland
Councilor for Veterinary Virology

Improving the control of veterinary viruses requires a holistic, integrated approach, involving academia, government and industry labs undertaking research into fundamental basic virology, as well as vaccine-related research, epidemiology, and surveillance. This satellite symposium aims to highlight these different roles, with talks from experts in different sectors, studying a variety of viral diseases of importance to livestock, companion animals, and wildlife. By bringing together the veterinary virology community, this symposium will stimulate discussion, collaboration, and novel research avenues, as well as showcasing the wealth of opportunities the veterinary profession has to offer virology trainees.

Speakers

SARS-CoV-2 in white-tailed deer
Andrew Bowman, The Ohio State University

The evolving highly pathogenic avian influenza (HPAI) situation in the US
Erica Spackman, USDA-Agricultural Research Service

Dissecting the replication complex of foot-and-mouth disease virus
Nicola Stonehouse, University of Leeds

African swine fever virus (ASFV) genotyping and vaccine development
Douglas Gladue, United States Department of Agriculture

Virology, Vaccines and Poultry: An Industry Perspective
Claudia Osorio, Elanco Animal Health

Emergence and evolution of H3N8 and H3N2 canine influenza virus, and comparison with the H3N8 equine influenza virus
Colin Parrish, Cornell University

Studying Bats Using a One Health Lens: Bridging the Gap Between Bat Virology and Disease Ecology

Organizers: Arinjay Banerjee, University of Saskatchewan; Stephanie Seifert, Washington State University; Hannah Frank, Tulane University; Daniel Becker, University of Oklahoma; Tony Schountz, Colorado State University

Accumulating data suggest that some bat species are hosts to emerging viruses, including coronaviruses, filoviruses, and paramyxoviruses, among others. In addition, emerging field studies have identified the critical impact of intrinsic and extrinsic factors on bat health that correlate with enhanced virus shedding in these mammals. This satellite symposium will bring together bat virologists, immunologists, biologists, and disease ecologists to better integrate field and laboratory studies of bat infectious diseases. The symposium will conclude with discussions around interdisciplinary collaborations, bat resource and reagent sharing, and opportunities for team grants.

Speakers

Sero-surveillance as a tool to identify most probable bat hosts and population-level prevalences of zoonotic viruses
Eric Laing, Uniformed Services University of the Health Sciences

Functional viromics of betacoronavirus entry
Michael Letko, Washington State University

Assessing pathogenic potential and risk factors of newly discovered bat-derived filoviruses

Elke Muhlberger, Boston University

Virus-driven selection and immunogenetic evolution in bats"
Hannah Frank, Tulane University

Capturing ancillary ecological data during field biosurveillance - getting the most bat for your buck
Kendra Phelphs, EcoHealth Alliance

Bat long-distance migration, immunity, and viral dynamics in the wild
Daniel Becker, University of Oklahoma

Open discussion on where the bat virology and disease ecology fields are headed and how we may synergize our scientific efforts
Arinjay Banerjee, University of Saskatchewan

Navigating Virology Funding Opportunities with NIH, NSF and USDA

Organizers: Joanna Shisler, NSF; Michelle Arnold, NIAID

In an increasingly competitive funding landscape where resources can be limited, it is essential for researchers to develop the skills to use a multi-pronged approach to raise funds for their projects. The process of identifying funding sources and writing grant applications to different funding bodies with diverse missions can be daunting, but there are strategies that applicants can use to target their projects and craft strong grant proposals that are tailored to grant-awarding institutions. By bringing together a variety of perspectives from different funding agencies and from grantees who have been supported by multiple organizations, the session will challenge participants to think about ways to further develop their own funding portfolio and creatively pitch their ideas. This symposium will highlight some of the strategic commonalities and differences across the funding landscape. The target audience will be junior investigators and trainees.

Speakers

Funding from the National Institutes of Health (NIH): Research awards to understand, protect, and improve human health
Training awards from the National Institutes of Health (NIH): Enhancing research training at all career stages
Michelle Arnold, National Institute of Allergy and Infectious Diseases

Stay in the game: Pursuing funding to support your research program
Helen Lazear, University of North Carolina at Chapel Hill

Funding from the US Department of Agriculture (USDA): Supporting the science of agriculture and natural resources
Christie Mayo, Colorado State University

Funding from the National Science Foundation (NSF): Advancing the progress of science by funding basic research – opportunities across career stage and institution size
Joanna Shisler, National Science Foundation

Lessons learned: Seeking diverse funding as a junior PI in virology
Mark Stenglein, Colorado State University

Virology in a Global Society

Organizers: Stacey Schultz-Cherry, St Jude Children’s Research Hospital; Felicia Goodrum, University of Arizona; Pedro Jimenez-Bluhm, Pontificia University; Erik Karlsson, Institut Pasteur du Cambodge; Ana Vazquez-Pagan, UJMT Fogarty

The COVID-19 pandemic highlighted the need to strengthen the global virology community. Through the generous support of the Gates Foundation, ASV expanded its Global Scholars program to provide support for more virologists from low-to-middle income countries (LMICs) to attend ASV. We are pleased to now host the Global Scholars Symposium, which provides a unique forum for past and present ASV Global Scholars to present their research, network, learn more about topics/opportunities suggested by past Scholars, and build collaborations. It also affords an opportunity for ASV membership at large to hear more about virology affecting LMICs. Everyone is encouraged to attend.

Speakers
ASV 2024 Global Scholar Awardees will be speaking at this event.

Development of field-forward environmental surveillance to advance early warning
Erik Karlsson, Deputy Head of Virology Unit, Director of National Influenza Center and WHO H5 Reference Laboratory Coordinator, and WHO global COVID-19 Referral Laboratory, Institut Pasteur du Cambodge, Cambodia

Exploring the effects of AHR/Axl pathway modulation on in vitro infections
Cybele Garcia, University of Buenos Aires, Argentina

Influenza virus infection in vulnerable populations
Ana Vazquez-Pagan, UJMT Fogarty Global Health Post-Doctoral Fellow, Weill Cornell Medicine | Noguchi Medical Research Institute (NMRI) Ghana

Avian influenza unplugged: tracing the viral trails of wild birds in Chile
Pedro Jiménez Bluhm,Pontificia Universidad Católica de Chile

Topoisomerase II as a Novel Antiviral Target against Panarenaviral Diseases
Tosin Afowowe, Nigeria Centre for Disease Control and Prevention

Candidatus Liberibacter asiaticus transmission efficiency and biology of Diaphorina citri modulated by insect-specific virus
Diogo Manzano Galdeano, Universidade Federal de Viçosa Brazil

A functional interaction between GRP78 and Zika virus E protein
Sarawut Khongwichit, Mahidol University, Thailand

Sarbecovirus broadly neutralising antibodies target the highly conserved N343 RBD glycosylation site
Dale Kitchin, National Institute for Communicable Diseases, South Africa

Efficacy of Newcastle Disease Virus–Based Vectored Vaccine Against H5N1 Highly Pathogenic Avian Influenza Virus Challenge in SPF Chicken
Katherine Calderon, FARVET S.A.C, Peru

Hepatitis C virus (HCV) infection among patients with sickle cell disease at the Korle-Bu teaching hospital
Gifty Mawuli Sarpong, Noguchi Memorial Institute for Medical Research, University of Ghana

Extensive host lncRNA expression profiling in Rotavirus infection revealed xCT mediated ferroptosis induction by upregulation of SLC7A11-AS1
Shreya Banerjee, ICMR-National Institute of Cholera and Enteric Diseases, India

Genetic diversity and transmission cluster analysis of HIV-1 in three neighbouring coastal countries of West-Africa: Predominance of URFs with mosaics of CRF02_AG and A3
Aristid Ekollo Mbange, Institut de Recherche en Santé, de Surveillance Epidémiologique et de Formation, Cameroon

Characterization of a Dengue/Zika outbreak in the Caribbean Region of Costa Rica during 2017-2018
Tatiana Murillo
, University of Costa Rica

Role of Micro RNA Profiling in Monitoring Human Immunodeficiency Virus Progression
Karen Pomeyie
, University of Cape Coast, Ghana

 

 

 

 

Schedule at a Glance

All event times are in the Eastern Time Zone (GMT-4)
Times are subject to change.

2024 Week at a Glance

Concurrent Workshop Schedule

Monday, June 24
7:00 p.m. - 8:30 p.m.
W1: Epidemiology & Public Health I
W2: Astroviruses
W3: Filoviruses I
W4: Innate Immune Effector Functions I
W5: Novel Methodology & Technology I
W6: Bunyaviruses I
W7: Vaccines I
W8: Orthomyxoviruses I
W9: Adeno-, Papilloma-, & Polyomaviruses
W10: Coronaviruses & Arteriviruses I
Tuesday, June 25
1:30 p.m. - 5:30 p.m.
W11: Evolution, Ecology, & Reservoirs
W12: Picornaviruses
W13: Trafficking, Assembly, Egress & Transmission
W14: Flaviviruses I
W15: Paramyxoviruses & Pneumoviruses I
W16: Herpesviruses I
W17: Plant Viruses I
W18: Poxviruses
W19: Reoviruses & Birnaviruses
W20: Coronaviruses & Arteriviruses II
Tuesday, June 25
7:00 p.m. - 8:30 p.m.
W21: Veterinary Virology
W22: Epidemiology & Public Health II
W23: Filoviruses II
W24: Hepatitis Viruses
W25: Retroviruses I
W26: Herpesviruses II
W27: Plant Viruses II
W28: Adaptive Immunity
W29: Antiviral Therapies I
W30: Coronaviruses & Arteriviruses III
W31: Careers in Industry Workshop I
Wednesday, June 26
1:30 p.m. - 5:30 p.m.
W32: Viruses of Other Microbes and Virus Discovery
W33: Arthropod-borne viruses
W34: Emerging Viruses
W35: Flaviviruses II
W36: Innate Immune Sensing
W37: Receptors, Attachment & Entry
W38: Vaccines II -
W39: Orthomyxoviruses II
W40: Antiviral Therapies II
W41: Coronaviruses & Arteriviruses IV
Wednesday, June 26
7:00 p.m. - 8:30 p.m.
W42: Innate Immune Effector Functions II
W43: Rotaviruses
W44: Viral Interference with Host Defense
W45: Togaviruses
W46: Paramyxoviruses & Pneumoviruses II
W47: Chronic, Latent, & Persistent Infections
W48: Arenaviruses
W49: Virus-based Therapies & Viral Vectors
W50: Replication & Gene Expression
W51: Coronaviruses & Arteriviruses V
W52: Careers in Industry Workshop II
Thursday, June 27
1:30 p.m. - 5:30 p.m.
W53: Novel Methodology & Technology II
W54: Caliciviruses
W55: Bunyaviruses II
W56: Flaviviruses III
W57: Retroviruses II
W58: Herpesviruses III
W59: Vaccines III
W60: Orthomyxoviruses III
W61: Structural Virology & RNA Biology
W62: Coronaviruses & Arteriviruses VI
Scroll to Top